Showing results (1781-1790 of 1,873) with videos related to

Sort By:
Pageof 188
Journal of Cardiac Failure|March 17, 2024
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4Ahmad Masri, Mark V Sherrid, Theodore P Abraham, et al.
Plos One|July 24, 2020
Pre-existing traits associated with Covid-19 illness severityJoseph E Ebinger, Natalie Achamallah, Hongwei Ji, et al.
JACC. Heart Failure|March 7, 2023
Dapagliflozin in Black and White Patients With Heart Failure Across the Ejection Fraction SpectrumJawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
Circulation|November 7, 2022
Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVERXiaowen Wang, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|June 7, 2025
A Nationwide Factorial Randomized Trial of Electronic Nudges to Patients With Chronic Kidney Disease and Their General Practices for Increasing Guideline-Directed Medical Therapy: The NUDGE-CKD TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Lisbet Brandi, et al.
Circulation|August 27, 2022
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER TrialJawad H Butt, Pardeep S Jhund, Jan Belohlávek, et al.
Trials|April 2, 2023
Clinical decision support to Optimize Care of patients with Atrial Fibrillation or flutter in the Emergency department: protocol of a stepped-wedge cluster randomized pragmatic trial (O'CAFÉ trial)David R Vinson, Adina S Rauchwerger, Chandu A Karadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2019
Genomic and molecular characterization of preterm birthTheo A Knijnenburg, Joseph G Vockley, Nyasha Chambwe, et al.
European Heart Journal|August 22, 2020
Effect of dapagliflozin according to baseline systolic blood pressure in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure trial (DAPA-HF)Matteo Serenelli, Michael Böhm, Silvio E Inzucchi, et al.
European Journal of Heart Failure|September 13, 2021
Recovery of cardiac function following COVID-19 - ECHOVID-19: a prospective longitudinal cohort studyMats C H Lassen, Kristoffer Grundtvig Skaarup, Jannie N Lind, et al.
Pageof 188